Details for 2016718802

Up to date per 04.04.2026

Actions

Title / Product Name

KOMBINATIONSTHERAPIE GEGEN KREBS

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2016718802

EP Publication Number

3283527

E-Number

1354505

Language

PCT Number

US16027038

Publication Date

21.02.2018 A

13.01.2021 B1

Registration Date

13.01.2021

AT Publication Date

15.02.2021

Application Date

12.04.2016

Registration Number

Priorities

13.04.2015

201562146766 P

10.07.2015

201562190945 P

IPC

C07K 16/28 20060101AFI20190131BHEP

Maximum Duration of Protection

12.04.2036

Owner

Five Prime Therapeutics, Inc.111 Oyster Point Boulevard South San Francisco, CA 94080US

Representative

Patentanwalt Mikšovsky KGBisamberger Straße 192100 KorneuburgAT

Inventor

MASTELLER, EmmaTwo Corporate Drive South San Francisco, California 94080US

BRENNAN, ThomasTwo Corporate Drive South San Francisco, California 94080US

BELLOVIN, DavidTwo Corporate Drive South San Francisco, California 94080US

BAKER, KevinTwo Corporate Drive South San Francisco, California 94080US

WONG, BrianTwo Corporate Drive South San Francisco, California 94080US